VK2735 + Placebo
Phase 2Completed 0 views this week 0 watching💤 Quiet
Interest: 32/100
32
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Weight Loss
Conditions
Weight Loss
Trial Timeline
Aug 31, 2023 → Apr 2, 2024
NCT ID
NCT06068946About VK2735 + Placebo
VK2735 + Placebo is a phase 2 stage product being developed by Viking Therapeutics for Weight Loss. The current trial status is completed. This product is registered under clinical trial identifier NCT06068946. Target conditions include Weight Loss.
What happened to similar drugs?
3 of 20 similar drugs in Weight Loss were approved
Approved (3) Terminated (1) Active (16)
Hype Score Breakdown
Clinical
12
Activity
8
Company
12
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT06068946 | Phase 2 | Completed |
Competing Products
20 competing products in Weight Loss